September 15-17, 2017

COURSE OVERVIEW

This course is designed to give a current review of thoracic pathology with clinical and radiologic  correlations. The course will run for two and one half days and will consist of a series of presentations with some multidisciplinary sessions regarding lung cancer, interstitial lung disease and non-neoplastic lung disease. Updates on the WHO Classification of Lung Tumors, the 8th Edition TNM Staging Classification, and ATS/ ERS Classification of Idiopathic Interstitial Pneumonias will be presented. Most of the speakers will be expert lung pathologists, but there will also be clinical and radiologic presentations by wellknown thoracic clinicians and radiologists. The presentations will illustrate the importance of a multidisciplinary approach to solving difficult problems in thoracic disease. Self Assessment Module Credits (SAMs) will be available.

 

The course will be held on the campus of Memorial Sloan Kettering Cancer Center on the Upper East  Side of Manhattan, a vibrant and safe neighborhood within easy access of the widely varied cultural attractions of New York City.

 

OBJECTIVES

By the end of this course the participant should:

• Have a grasp of current concepts in lung, pleural and mediastinal pathology
• Understand the importance of correlation between clinical, radiologic and pathologic data in diagnosis and management of interstitial lung disease and pulmonary vasculitis
• Know the significance of lung biopsy and multidisciplinary correlation for the diagnosis of non-neoplastic lung disease in acute lung injury and in cancer patients
• Comprehend the most recent histologic concepts in lung cancer diagnosis and classification including the impact of radiologic correlation on pathology diagnosis.
• Realize the important issues in molecular targeted therapy for lung adenocarcinoma
• Have a practical understanding of differential diagnosis for mediastinal and pleural lesions
• Understand the usefulness of cytology in pulmonary, pleural and mediastinal diagnoses

 

Target Audience

This course will be invaluable for pathologists, pulmonologists, thoracic surgeons, and radiologists, including physicians in training.

 

Course Design

The course will run for two and one half days and will consist of a series of presentations with some multidisciplinary sessions regarding lung adenocarcinoma, interstitial lung disease and non-neoplastic lung disease in cancer patients.

 

Evaluation

A course evaluation survey sent out electronically will provide attendees with the opportunity to review the sessions and the speakers and to identify future educational needs.

 

AMA Credit Designation Statement

MSK designates this live activity for a maximum of 18.25 AMA PRA Category 1 Credits™.  Physicians should only claim credit commensurate with the extent of their participation in the activity. The AMA has determined that physicians not licensed in the United States but who participate in this CME activity are eligible for 18.25 AMA PRA Category 1 Credit(s)™.

 

Accredition Creditation Statement

MSK is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Faculty Disclosure

It is the policy of MSK to make every effort to insure balance, independence, objectivity, and scientific rigor in all continuing medical education activities which it sponsors as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity sponsored by MSK are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by the ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational.

 

Outcomes Measurement Survey

Six months after the end of the course an Outcomes Measurement Survey will be sent to all participants to help us determine what positive impacts have been made on participant practice as a result of the course.

 

SELF ASSESSMENT MODULES (SAMS)

This program will include SAM Credits.  Number to be determined pending approval from the American Board of Pathology (ABP).

 

REGISTRATION

COURSE LOCATION

Memorial Sloan Kettering Cancer Center

ROCKEFELLER RESEARCH LABORATORIES

430 East 67th Street (between First and York Avenues)

http://www.mskcc.org/thoracicpathology2017

New York City | 2017

Thoracic Pathology

September 15-17, 2017

New York City | 2017

To register or for more information, please go to: http://www.mskcc.org/thoracicpathology2017 

 

 

EARLY* GENERAL

$595 $695 MDs, PhDs and DOs

$289 $329 Fellows, Residents, and RNs

 

*Deadline is August 7, 2017.

Registration fee includes an electronic syllabus and other related hand-out materials, continental breakfast, lunch, and refreshment breaks. Special meals are available upon request, including vegetarian, kosher, or gluten-free. Please let us know if we can assist you with special dietary needs.

To register to attend please go to: http://www.mskcc.org/thoracicpathology2017 

 

 

Or contact:

SARAH B. VIRGO

Education & Communications Coordinator, Department Of Pathology

Memorial Sloan Kettering Cancer Center

1275 York Avenue, H-504, New York, New York 10065

(212) 639.5696 | cooks@mskcc.org